Literature DB >> 25906717

First-in-man endovascular preconditioning of the paraspinal collateral network by segmental artery coil embolization to prevent ischemic spinal cord injury.

Christian D Etz1, E Sebastian Debus2, Friedrich-Wilhelm Mohr3, Tilo Kölbel2.   

Abstract

OBJECTIVE: Spinal cord injury remains an invincible complication affecting up to 1 of 5 patients after thoracoabdominal aortic aneurysm repair. A staged surgical approach has been suggested to eliminate paraplegia by induction of arteriogenesis within the paraspinal collateral network; however, its clinical implementation was deferred because it required 2 major procedures.
METHODS: First-in-man experience with minimally invasive, selective segmental artery endovascular coil embolization before Crawford type II and III thoracoabdominal aortic aneurysm repair for arteriogenic preconditioning of the collateral network is reported. A 45-year-old man received bilateral elective minimally invasive, selective segmental artery endovascular coil embolization of 2 unilateral lumbar segmental arteries 4 weeks before open surgical repair. A 67-year-old woman who was planned for total endovascular treatment received minimally invasive, selective segmental artery endovascular coil embolization at the fourth lumbar level and coil embolization of the inferior mesenteric artery 8 weeks before endovascular repair.
RESULTS: Minimally invasive, selective segmental artery endovascular coil embolization was technically successful and did not result in any neurologic impairment. Both patients were discharged after 72 hours of clinical surveillance. Patient 1 returned for definite open single-stage thoracoabdominal aortic aneurysm repair after 4 weeks and left the hospital without any neurologic impairment on day 35 postoperatively. Patient 2 returned for total endovascular repair 8 weeks after she underwent minimally invasive, selective segmental artery endovascular coil embolization; she recovered well and was discharged without spinal cord injury 8 days after extensive single-stage endovascular thoracoabdominal aortic aneurysm repair. Both patients are alive with no neurologic injury at 1-year follow-up.
CONCLUSIONS: Minimally invasive, selective segmental artery endovascular coil embolization for arteriogenic preconditioning of the paraspinal arterial collateral network is clinically feasible and may eventually eliminate ischemic spinal cord injury to enable safe open or endovascular repair of extensive thoracoabdominal aortic aneurysms and prevent paraplegia altogether in the near future.
Copyright © 2015 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  endovascular segmental coil—embolization; spinal cord injury; staged TAA/A—repair

Mesh:

Year:  2014        PMID: 25906717     DOI: 10.1016/j.jtcvs.2014.12.025

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  14 in total

1.  Risk factors for spinal cord injury in patients undergoing frozen elephant trunk technique for acute aortic dissection.

Authors:  Daijiro Hori; Sho Kusadokoro; Koichi Adachi; Naoyuki Kimura; Koichi Yuri; Harunobu Matsumoto; Atsushi Yamaguchi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-08-29

Review 2.  Spinal cord injury after thoracic endovascular aortic aneurysm repair.

Authors:  Hamdy Awad; Mohamed Ehab Ramadan; Hosam F El Sayed; Daniel A Tolpin; Esmerina Tili; Charles D Collard
Journal:  Can J Anaesth       Date:  2017-10-10       Impact factor: 5.063

3.  Motor evoked potential-guided segmental artery revascularization during open thoracoabdominal aortic aneurysm surgery after coil embolization as a part of the minimally invasive staged segmental artery coil embolization concept.

Authors:  Panagiotis Doukas; Alexander Gombert; Drosos Kotelis; Michael J Jacobs
Journal:  J Vasc Surg Cases Innov Tech       Date:  2022-03-08

4.  Perioperative cerebrospinal fluid drainage for the prevention of spinal ischemia after endovascular aortic repair.

Authors:  M Wortmann; D Böckler; P Geisbüsch
Journal:  Gefasschirurgie       Date:  2017-05-16

5.  Anatomic study of the vascular perfusion of the sternum and its clinical relevance in deep sternal wound infection.

Authors:  Nick Spindler; Florian Kaatz; Christine Feja; Christian Etz; Friedrich-Wilhelm Mohr; Ingo Bechmann; Christoph Josten; Stefan Langer; Sabine Loeffler
Journal:  GMS Interdiscip Plast Reconstr Surg DGPW       Date:  2017-06-06

6.  Paraplegia prevention in aortic aneurysm repair by thoracoabdominal staging with 'minimally invasive staged segmental artery coil embolisation' (MIS²ACE): trial protocol for a randomised controlled multicentre trial.

Authors:  David Petroff; Martin Czerny; Tilo Kölbel; Germano Melissano; Lars Lonn; Josephina Haunschild; Konstantin von Aspern; Petra Neuhaus; Johann Pelz; David Mark Epstein; Nuria Romo-Avilés; Katja Piotrowski; Christian D Etz
Journal:  BMJ Open       Date:  2019-03-04       Impact factor: 2.692

7.  The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits.

Authors:  Jin Zhou; Jie Li; Daniel M Rosenbaum; Jian Zhuang; Carrie Poon; Pu Qin; Katrina Rivera; John Lepore; Robert N Willette; Erding Hu; Frank C Barone
Journal:  PLoS One       Date:  2017-09-07       Impact factor: 3.240

Review 8.  Staged procedures for prevention of spinal cord ischemia in endovascular aortic surgery.

Authors:  F Heidemann; N Tsilimparis; F Rohlffs; E S Debus; A Larena-Avellaneda; S Wipper; T Kölbel
Journal:  Gefasschirurgie       Date:  2018-07-02

Review 9.  Arteriogenesis of the Spinal Cord-The Network Challenge.

Authors:  Florian Simon; Markus Udo Wagenhäuser; Albert Busch; Hubert Schelzig; Alexander Gombert
Journal:  Cells       Date:  2020-02-22       Impact factor: 6.600

10.  Commentary: Cerebrospinal fluid drainage: One component of a successful distal aortic surgery program.

Authors:  Marina Ibrahim; Jennifer C-Y Chung; Thomas F Lindsay; Maral Ouzounian
Journal:  JTCVS Tech       Date:  2021-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.